Skip to main content
SpringerLink
Log in

One Intraoperative Dose of Tranexamic Acid for Patients Having Primary Hip or Knee Arthroplasty

  • Clinical Research
  • Published:
Clinical Orthopaedics and Related Research®

An Erratum to this article was published on 09 March 2010

Abstract

Background

Multiple studies suggest tranexamic acid reduces blood loss and red cell transfusions in patients undergoing THA or TKA. However, many of the dosing schedules in these studies are not ideally suited for routine application.

Questions/purposes

We asked whether one 20-mg per kg intraoperative dose of tranexamic acid in patients having primary THA or TKA would (1) decrease perioperative blood loss and red cell transfusion rates and (2) be a cost-effective protocol.

Patients and Methods

We retrospectively reviewed the records of 234 patients operated on from April 1 to June 30, 2007 (before our study protocol) and 259 patients from April 1 to June 30, 2008 with the single-dose protocol. We then compared change in hemoglobin, transfusion rates, hemoglobin at discharge, hospital length of stay, and complications between the two groups. No other routine patient care practices or blood conservation program strategies were altered during this time.

Results

We found a reduction in the decrease in hemoglobin in 2007 compared with 2008 for THA and TKA (46 to 39 g/L and 45 to 36 g/L, respectively), which led to a reduction in transfusion rates (13.5% to 3.6% and 13.1% to 2.0%, respectively) and higher hemoglobin levels at discharge. There were no recorded major adverse events associated with the introduction of this protocol.

Conclusions

One 20-mg per kg intraoperative dose of tranexamic acid reduced the perioperative decrease in hemoglobin and red blood cell transfusion rates in patients having TKA and THA compared with those of a similar cohort of patients in whom the protocol was not used. This weight increment dosing facilitated pharmacy drug preparation, led to minimal dose variability and wastage, and resulted in a substantial estimated cost savings.

Level of Evidence

Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion. 2008;48:519–525.

    Article  PubMed  Google Scholar 

  2. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl. 1987;137;22–25.

    Article  CAS  PubMed  Google Scholar 

  3. Camarasa MA, Ollé G, Serra-Prat M, Martín A, Sánchez M, Ricós P, Pérez A, Opisso L. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006;96:576–582.

    Article  CAS  PubMed  Google Scholar 

  4. Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005;45:1302–1307.

    Article  CAS  PubMed  Google Scholar 

  5. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg. 2007;107:397–401.

    CAS  PubMed  Google Scholar 

  6. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–2331.

    Article  CAS  PubMed  Google Scholar 

  7. Freedman J, Luke K, Monga N, Lincoln S, Koen R, Escobar M, Chiavetta J. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apher Sci. 2005;33:343–349.

    Article  CAS  PubMed  Google Scholar 

  8. Gill JB, Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. J Arthroplasty. 2006;21:869–873.

    Article  PubMed  Google Scholar 

  9. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care. 2003;31:529–537.

    CAS  PubMed  Google Scholar 

  10. Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 2005;76:314–319.

    PubMed  Google Scholar 

  11. Juelsgaard P, Larsen UT, Sorensen JV, Madsen F, Soballe K. Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med. 2001;26:105–110.

    CAS  PubMed  Google Scholar 

  12. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009;123:687–696.

    Article  CAS  PubMed  Google Scholar 

  13. Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, Salazar F, Cid J, Lozano L, Mazzara R, Macule F. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang. 2008;95:39–44.

    Article  CAS  PubMed  Google Scholar 

  14. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339:245–253.

    Article  CAS  PubMed  Google Scholar 

  15. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br. 2007;89:306–309.

    Article  CAS  PubMed  Google Scholar 

  16. Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ. Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg. 2007;142:126–132; discussion 133.

    Article  PubMed  Google Scholar 

  17. Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop. 2005;76:829–832.

    Article  PubMed  Google Scholar 

  18. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee. 2006;13:106–110.

    Article  PubMed  Google Scholar 

  19. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br. 2009;91:776–783.

    Article  CAS  PubMed  Google Scholar 

  20. Sharrock NE, Mineo R, Urquhart B, Salvati EA. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg. 1993;76:580–584.

    CAS  PubMed  Google Scholar 

  21. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, Chapman CE, Davison K, Gerrard R, Gray A, Knowles S, Love EM, Milkins C, McClelland DB, Norfolk DR, Soldan K, Taylor C, Revill J, Williamson LM, Cohen H; SHOT Steering Group. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006;20:273–282.

    Article  PubMed  Google Scholar 

  22. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006;105:1034–1046.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge Drs. Steven MacDonald, James McAuley, Richard McCalden, and Robert Bourne for contribution of their patients to this study and Jeff Guerin for assistance with statistical analysis.

Author information

Authors and Affiliations

  1. Department of Anesthesia and Perioperative Medicine, University of Western Ontario, London, ON, Canada

    Fiona E. Ralley BSc, MBChB, FRCA, FRCSC

  2. Ontario Transfusion Coordinators (ONTraC), London, ON, Canada

    Donna Berta RN & Valerie Binns RN

  3. Division of Orthopaedic Surgery, University of Western Ontario, London, ON, Canada

    James Howard MD, MSc, FRCSC & Douglas D. R. Naudie MD, FRCSC

  4. Division of Orthopaedic Surgery, London Health Sciences Center, University Hospital, A9-028, 339 Windermere Road, London, ON, N6A 5A5, Canada

    Douglas D. R. Naudie MD, FRCSC

Authors
  1. Fiona E. Ralley BSc, MBChB, FRCA, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donna Berta RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valerie Binns RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Howard MD, MSc, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Douglas D. R. Naudie MD, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas D. R. Naudie MD, FRCSC.

Additional information

The institution of one or more of the authors (JH, DN) has received funding from Smith and Nephew (Memphis, TN), DePuy (Warsaw, IN), and Stryker (Mahwah, NJ).

Each author certifies that his or her institution approved the protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.

This work was performed at London Health Sciences Center.

An erratum to this article can be found at http://dx.doi.org/10.1007/s11999-010-1270-3

About this article

Cite this article

Ralley, F.E., Berta, D., Binns, V. et al. One Intraoperative Dose of Tranexamic Acid for Patients Having Primary Hip or Knee Arthroplasty. Clin Orthop Relat Res 468, 1905–1911 (2010). https://doi.org/10.1007/s11999-009-1217-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-009-1217-8

Keywords

Search

Navigation